Fosun Pharma (02196) Proposes Executive Director Election, Schedules EGM in December

Bulletin Express

11/07

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has released details of an upcoming extraordinary general meeting (EGM) to vote on the proposed election of a new executive director. The EGM is set for December 2, 2025, at 1:30 p.m., to be held at Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.

The candidate for executive director is Liu Yi, currently serving as the chief executive officer and president of the company. If approved, Liu Yi’s term will extend until the end of the tenth session of the board. According to the announcement, Liu Yi holds personal interests in 15,444 A shares and 20,000 H shares of the company.

The register of H shareholders is scheduled to close from November 27 to December 2, 2025 (inclusive), with the record date on December 2, 2025. Unregistered H shareholders intending to vote at the meeting should submit relevant transfer documents by 4:30 p.m. on November 26, 2025.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1120611204"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120611204\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120611204?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 16:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120611204","market":"us","top_or_hot":-1,"title":"Fosun Pharma (02196) Proposes Executive Director Election, Schedules EGM in December","media":"Bulletin Express","content":"<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has released details of an upcoming extraordinary general meeting (EGM) to vote on the proposed election of a new executive director. The EGM is set for December 2, 2025, at 1:30 p.m., to be held at Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.</p>\n<p>The candidate for executive director is Liu Yi, currently serving as the chief executive officer and president of the company. If approved, Liu Yi’s term will extend until the end of the tenth session of the board. According to the announcement, Liu Yi holds personal interests in 15,444 A shares and 20,000 H shares of the company.</p>\n<p>The register of H shareholders is scheduled to close from November 27 to December 2, 2025 (inclusive), with the record date on December 2, 2025. Unregistered H shareholders intending to vote at the meeting should submit relevant transfer documents by 4:30 p.m. on November 26, 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fosun Pharma (02196) Proposes Executive Director Election, Schedules EGM in December</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFosun Pharma (02196) Proposes Executive Director Election, Schedules EGM in December\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-07 16:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has released details of an upcoming extraordinary general meeting (EGM) to vote on the proposed election of a new executive director. The EGM is set for December 2, 2025, at 1:30 p.m., to be held at Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.</p>\n<p>The candidate for executive director is Liu Yi, currently serving as the chief executive officer and president of the company. If approved, Liu Yi’s term will extend until the end of the tenth session of the board. According to the announcement, Liu Yi holds personal interests in 15,444 A shares and 20,000 H shares of the company.</p>\n<p>The register of H shareholders is scheduled to close from November 27 to December 2, 2025 (inclusive), with the record date on December 2, 2025. Unregistered H shareholders intending to vote at the meeting should submit relevant transfer documents by 4:30 p.m. on November 26, 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02196","symbol_name":"复星医药","start_time":0,"source_url":"","article_id":"1120611204","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120611204","pubTimestamp":1762503746,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has released details of an upcoming extraordinary general meeting (EGM) to vote on the proposed election of a new executive director. The EGM...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02196":"复星医药"},"translate_title":"复星医药(02196)建议选举执行董事安排12月临时股东大会","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02196":1},"content_text":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has released details of an upcoming extraordinary general meeting (EGM) to vote on the proposed election of a new executive director. The EGM is set for December 2, 2025, at 1:30 p.m., to be held at Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.\nThe candidate for executive director is Liu Yi, currently serving as the chief executive officer and president of the company. If approved, Liu Yi’s term will extend until the end of the tenth session of the board. According to the announcement, Liu Yi holds personal interests in 15,444 A shares and 20,000 H shares of the company.\nThe register of H shareholders is scheduled to close from November 27 to December 2, 2025 (inclusive), with the record date on December 2, 2025. Unregistered H shareholders intending to vote at the meeting should submit relevant transfer documents by 4:30 p.m. on November 26, 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}